Dr. Donald Scott, MD
What this data tells you about Dr. Scott
Dr. Donald Scott is a rheumatology specialist in Gainesville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scott performed 29,181 Medicare services across 5,657 unique beneficiaries.
Between the years covered by Open Payments, Dr. Scott received a total of $272 from 4 pharmaceutical and/or device companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scott is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 78979 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 16,380 | $18 | $29 |
| Infliximab infusion (Remicade) | 2,400 | $26 | $70 |
| Office visit, established patient (30-39 min) | 1,663 | $91 | $195 |
| Office visit, established patient (20-29 min) | 1,052 | $65 | $137 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 908 | $17 | $38 |
| Comprehensive metabolic blood panel | 584 | $10 | $49 |
| Complete blood count (CBC) with differential | 544 | $8 | $25 |
| Physical therapy exercise, per 15 min | 371 | $18 | $42 |
| Drug injection, under skin or into muscle | 360 | $11 | $30 |
| Blood draw (venipuncture) | 349 | $8 | $15 |
| Vitamin D level test | 348 | $29 | $79 |
| Cardiolipin antibody (tissue antibody) measurement | 329 | $24 | $53 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 312 | $4 | $25 |
| Measurement of complement (immune system proteins), antigen, | 282 | $11 | $25 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 221 | $24 | $38 |
| Basic metabolic blood panel | 210 | $8 | $47 |
| Manual therapy (hands-on treatment), per 15 min | 188 | $16 | $38 |
| Bone density scan (DEXA) | 172 | $37 | $135 |
| Rheumatoid factor level | 164 | $5 | $32 |
| C-reactive protein test (inflammation marker) | 158 | $5 | $29 |
| Neuromuscular re-education therapy, per 15 min | 150 | $23 | $43 |
| Measurement of antibody for rheumatoid arthritis assessment | 139 | $12 | $27 |
| Screening test for autoimmune disorder | 112 | $12 | $35 |
| Microsomal antibodies (autoantibody) measurement | 111 | $14 | $30 |
| Functional activity therapy | 103 | $29 | $44 |
| Joint injection, major joint | 98 | $67 | $202 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 91 | $54 | $200 |
| Injection, zoledronic acid, 1 mg | 90 | $5 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 89 | $48 | $100 |
| Ferritin level test (iron stores) | 69 | $13 | $76 |
| X-ray of hand, minimum of 3 views | 64 | $51 | $82 |
| X-ray of knee, 1-2 views | 63 | $34 | $56 |
| Administration of chemotherapy into vein, each additional hour | 63 | $22 | $100 |
| Vitamin B-12 level test | 60 | $15 | $84 |
| Injection, methylprednisolone acetate, 80 mg | 60 | $9 | $30 |
| Administration of chemotherapy into vein, 1 hour or less | 55 | $101 | $200 |
| New patient office visit (45-59 min) | 54 | $121 | $254 |
| Thyroid stimulating hormone (TSH) test | 53 | $16 | $94 |
| Uric acid level test | 51 | $4 | $25 |
| Parathyroid hormone level test | 41 | $40 | $85 |
| X-ray of wrist, minimum of 3 views | 37 | $56 | $110 |
| Mri scan of lower spinal canal without contrast | 34 | $156 | $826 |
| Chest X-ray, 2 views | 33 | $26 | $50 |
| Hip X-ray, 2-3 views | 32 | $33 | $60 |
| Shoulder X-ray, 2+ views | 30 | $29 | $58 |
| Injection, methylprednisolone acetate, 40 mg | 30 | $5 | $15 |
| Foot X-ray, 3+ views | 26 | $33 | $58 |
| Iron level test | 25 | $6 | $36 |
| Iron binding capacity test | 25 | $9 | $49 |
| Evaluation for physical therapy, typically 20 minutes | 24 | $68 | $105 |
| X-ray of upper spine, 2-3 views | 23 | $31 | $54 |
| Folic acid level test | 23 | $14 | $47 |
| New patient office visit (30-44 min) | 23 | $83 | $170 |
| X-ray of lower and sacral spine, 2-3 views | 22 | $31 | $57 |
| Mri scan of upper spinal canal without contrast | 20 | $153 | $765 |
| Mri scan of leg joint without contrast | 17 | $164 | $730 |
| Limited ultrasound scan of abdomen | 15 | $65 | $152 |
| Drug screening test | 15 | $61 | $120 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 15 | $195 | $245 |
| X-ray of both hips, 3-4 views | 14 | $39 | $70 |
| Lipid panel (cholesterol and triglycerides) | 13 | $13 | $75 |
| Free thyroxine (T4) test | 13 | $9 | $65 |
| Flu vaccine, high-dose | 13 | $66 | $80 |
| Evaluation for occupational therapy, typically 30 minutes | 13 | $73 | $111 |
| Flu vaccine administration | 13 | $27 | $30 |
| X-ray of middle spine, 3 views | 11 | $28 | $60 |
| Evaluation for physical therapy, typically 30 minutes | 11 | $72 | $105 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Scott is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Scott experienced with denosumab injection (prolia/xgeva)?
Does Dr. Scott receive payments from pharmaceutical companies?
How do Dr. Scott's costs compare to other rheumatologists in Gainesville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology